JP7650274B2 - ゾニサミド口腔分散性錠剤 - Google Patents

ゾニサミド口腔分散性錠剤 Download PDF

Info

Publication number
JP7650274B2
JP7650274B2 JP2022529813A JP2022529813A JP7650274B2 JP 7650274 B2 JP7650274 B2 JP 7650274B2 JP 2022529813 A JP2022529813 A JP 2022529813A JP 2022529813 A JP2022529813 A JP 2022529813A JP 7650274 B2 JP7650274 B2 JP 7650274B2
Authority
JP
Japan
Prior art keywords
zonisamide
disintegration
hardness
tablet
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022529813A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023502738A5 (https=
JP2023502738A (ja
JPWO2021099531A5 (https=
Inventor
ルカ ストルシ、オラツィオ
コデルク、モンセラート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biohorm SL
Original Assignee
Biohorm SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohorm SL filed Critical Biohorm SL
Publication of JP2023502738A publication Critical patent/JP2023502738A/ja
Publication of JP2023502738A5 publication Critical patent/JP2023502738A5/ja
Publication of JPWO2021099531A5 publication Critical patent/JPWO2021099531A5/ja
Application granted granted Critical
Publication of JP7650274B2 publication Critical patent/JP7650274B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022529813A 2019-11-22 2020-11-20 ゾニサミド口腔分散性錠剤 Active JP7650274B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19383034 2019-11-22
EP19383034.6 2019-11-22
PCT/EP2020/082809 WO2021099531A1 (en) 2019-11-22 2020-11-20 Zonisamide orodispersible tablets

Publications (4)

Publication Number Publication Date
JP2023502738A JP2023502738A (ja) 2023-01-25
JP2023502738A5 JP2023502738A5 (https=) 2023-11-08
JPWO2021099531A5 JPWO2021099531A5 (https=) 2023-11-08
JP7650274B2 true JP7650274B2 (ja) 2025-03-24

Family

ID=68808236

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022529813A Active JP7650274B2 (ja) 2019-11-22 2020-11-20 ゾニサミド口腔分散性錠剤

Country Status (5)

Country Link
EP (1) EP4061328B1 (https=)
JP (1) JP7650274B2 (https=)
ES (1) ES2976470T3 (https=)
PT (1) PT4061328T (https=)
WO (1) WO2021099531A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024090218A (ja) * 2022-12-22 2024-07-04 ダイト株式会社 崩壊遅延を改善したゾニサミド含有口腔内速崩壊錠
AU2024227385A1 (en) * 2024-03-28 2025-10-16 Athena Pharmaceutiques Sas Lisdexamfetamine dimesylate orodispersible tablet and process for preparation thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009102038A1 (ja) 2008-02-13 2009-08-20 Dainippon Sumitomo Pharma Co., Ltd. 口腔内崩壊錠
JP2012036140A (ja) 2010-08-10 2012-02-23 Kyoto Pharmaceutical Industries Ltd 苦味を抑制した速崩壊錠
WO2019064468A1 (ja) 2017-09-28 2019-04-04 武田テバファーマ株式会社 口腔内崩壊錠

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6230539B2 (ja) 2012-09-20 2017-11-15 株式会社ダイセル 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009102038A1 (ja) 2008-02-13 2009-08-20 Dainippon Sumitomo Pharma Co., Ltd. 口腔内崩壊錠
JP2012036140A (ja) 2010-08-10 2012-02-23 Kyoto Pharmaceutical Industries Ltd 苦味を抑制した速崩壊錠
WO2019064468A1 (ja) 2017-09-28 2019-04-04 武田テバファーマ株式会社 口腔内崩壊錠

Also Published As

Publication number Publication date
PT4061328T (pt) 2024-04-08
EP4061328A1 (en) 2022-09-28
JP2023502738A (ja) 2023-01-25
ES2976470T3 (es) 2024-08-01
EP4061328B1 (en) 2024-01-03
WO2021099531A1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
JP6325627B2 (ja) 口腔内崩壊錠及びその製造方法
RU2478375C2 (ru) Распадающаяся во рту таблетка
CA2563440C (en) Orally disintegrating tablets and methods of manufacture
ES3006182T3 (en) Pharmaceutical composition, comprising phosphate binder particles
CA2650498A1 (en) Orally disintegrating tablets
KR20030094272A (ko) 구강내 급속 붕괴성 정제
AU2006205817A1 (en) Orally disintegrating composition of olanzapine or donepezil
Jain et al. A review-formulation & development of orodispersible tablet
JPWO2015115453A1 (ja) 口腔内速崩壊性固形製剤用組成物
KR102024120B1 (ko) 신규한 (트리메톡시페닐아미노)피리미디닐 제형
JP7650274B2 (ja) ゾニサミド口腔分散性錠剤
EP4436553A1 (en) An orodispersible pharmaceutical dosage form of edoxaban
US20090209587A1 (en) Repaglinide formulations
JP4446177B2 (ja) 耐湿性口腔内崩壊錠の製造方法
JP5572321B2 (ja) 被覆微粒子含有口腔内崩壊錠
JP2005029557A (ja) 口腔内速崩壊性錠剤およびその製造方法
JP2011213695A (ja) ドネペジル塩酸塩含有口腔内速崩壊錠
Magar Formulation and evalution of oral dispersible tablets
Rai et al. A REVIEW ON: ORAL DISPERSIBLE TABLETS
Jangid et al. DISPERSIBLE TABLET AS A FORMULATION FOR ORAL DRUG DELIVERY SYSTEM
Kumar et al. Formulation and evaluation of oral disintegrating tablets of cinnarizine
HK1206983B (en) Orally disintegrating tablet and method for producing same

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231030

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231030

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241029

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241223

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250304

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250311

R150 Certificate of patent or registration of utility model

Ref document number: 7650274

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150